IRVINE, CALIFORNIA, March 12, 2015 – Inari Medical Inc., a venture capital backed medical device company focused on the interventional treatment of vascular thrombus and emboli, announced the treatment of the first patient with its FlowTriever Infusion Aspiration System. The FlowTriever System received 510(k) marketing clearance from the U.S. Food and Drug Administration (FDA) in February to treat emboli (blood clots) in the peripheral vasculature.

“We are pleased to be the first site to perform a procedure using the FlowTriever System,” said Dr. Tod Engelhardt, MD, chairman of the Cardiovascular and Thoracic Surgery Division of East Jefferson General Hospital in Metairie, Louisiana. “The FlowTriever offered an efficient, minimally invasive treatment and rapidly restored blood flow in the occluded vessel. I believe the FlowTriever is a promising new advancement in the treatment of vessels occluded by emboli.”

“The FlowTriever System is the first offering in Inari’s planned product portfolio,” said Bill Hoffman, Inari’s chief executive officer. “This device will be available for embolus treatment in peripheral applications at select centers and we plan to add additional centers as we gain clinical experience. We are pleased to provide a new tool for interventionalists to deal with emboli and rapidly restore flow in occluded vessels.” added Mr. Hoffman.

+ Read More

IRVINE, CALIFORNIA, February 9, 2015 – Bill Hoffman brings proven record of success in commercializing innovative therapies

Inari Medical, a medical device company pioneering innovative devices for the interventional treatment of cardiovascular disease announced today that Bill Hoffman has joined the company as President and Chief Executive Officer. A veteran medical device executive, Bill brings more than 25 years of experience to the role. Most recently, Bill served as President and CEO of Visualase, acquired by Medtronic in July 2014.

“We are delighted to welcome Bill to Inari,” said Bob Rosenbluth, Chairman of Inari’s Board of Directors and President and CEO of Inceptus. “He is an exceptional leader with a proven record of success in bringing innovative new therapies to market. I am confident that Bill’s strong commercial experience will serve Inari well in introducing its novel interventional system.”

+ Read More